BMA (1996) Reporting Adverse Drug Reactions. A BMA policy document. London: BMA.
Dunn NR, Freemantle S, Mann RD (1999) Nicorandil and diabetes: a nested case-control study to examine a signal generated by prescription-event monitoring. Eur J Clin Pharmacol 55: 159-62.
Dunn NR, Pearce GL, Shakir SAW (2000) Adverse effects associated with the use of donepezil in general practice in England. J Psychopharmacol 14: 406-8.
Finney DJ (1965) The design and logic of a monitor of drug use. J Chron Dis 18: 77-98.
Freemantle SN, Pearce GL, Wilton LV, et al. (1997) The incidence of the most commonly reported events with 40 newly marketed drugs—a study by Prescription-Event Monitoring. Pharmacoepidemiology and Drug Safety 6 (Suppl 1): 1-62.
Inman WHW (1978a) Detection and investigation of drug safety problems. In: Gent M, Shigematsu I, eds., Epidemiological Issues in Reported Drug-Induced Illnesses. Hamilton, Ontario: McMaster University Library Press.
Inman WHW (1978b) An introduction to Prescription-Event Monitoring. In: Mann RD, ed., Adverse Drug Reactions. Carnforth, UK: Parthenon Publishing, pp. 177-99.
Inman, WHW (1981a) Postmarketing surveillance of adverse drug reactions in general practice. I: Search for new methods. Br Med J 282: 1131-2.
Inman, WHW (1981b) Postmarketing surveillance of adverse drug reactions in general practice. II: Prescription-event monitoring at the University of Southampton. Br Med J 282: 1216-7.
Inman WHW, Rawson NSB, Wilton LV (1981) Prescription-event monitoring. In: Inman WHW, ed., Monitoring for Drug Safety, 2nd edn. Lancaster UK: MTP Press, pp. 213-35.
Layton D, Clark D, Pearce G, Shakir SAW (2001) Association between Selective Serotonin Reuptake Inhibitors (SSRI) and the risk of abnormal bleeding. Eur J Clin Pharmacol, in press.
Lenz, W (1961) Kindliche Missbildungen nach Medikament—Einnahme Während der Graviditat? Dtsch med Wschr 86: 2555.
Lenz, W. (1962) Thalidomide and congenital abnormalities. Lancet 1, 45.
MacKay F (1998) Postmarketing studies: the value of the work of the Drug Safety Research Unit. Drug Safety 19: 343-53.
MacKay F, Wilton LV, Pearce G, et al. (1997) Acarbose and gastrointestinal intolerance. Pharmacoepidemiology and Drug Safety 6 (Suppl 2): Abstract 044.
MacKay FJ, Wilton LV, Pearce G, et al. (1997) Alendronate and oesophageal reactions. Pharmaco-epidemiology and Drug Safety 6 (Suppl 2): Abstract 045.
MacKay FJ, Wilton LV, Pearce GL, et al. (1997) Safety of long-term lamotrigine in epilepsy. Epilepsia 38(8): 881 -6.
Mackay FJ, Dunn NR, Mann RD (1999) Antidepres-sants and the serotonin syndrome in general practice. Br J Gen Pract 49: 871-4.
Mann RD, Wilton LV, Pearce GL, et al. (1997) Prescription-event monitoring (PEM) in 1996. A method of non-interventional observational cohort pharmacovigilance. Pharmacoepidemiology and Drug Safety 6 (Suppl 3): S5-S11.
Martin RM, Dunn NR, Freemantle S, Shakir S (2000) The rates of common adverse events reported with treatment with proton pump inhibitors used in general practice in England: cohort studies. Br J Clin Pharmacol 11: 67-73.
Martin RM, Kapoor KV, Wilton LV, Mann RD (1998) Underreporting of suspected adverse drug reactions to newly marketed, black triangle drugs in general practice. Br Med J 317: 119-20.
Secretary of State for Social Services Medicines (adverse reactions) (1986) Hansard (Commons) (30 Jan.). Col. 622
Shakir S, Wilton LV, Heeley E, Layton D (2001) Cardiovascular events in users of sildenafil: results from first phase of prescription-event monitoring in England. Br Med J 322: 651-2.
Wilton LV, Freemantle S, Martin RM, Mann RD (1998) Is the incidence of upper respiratory infections independent of drug treatment in large cohort studies? Proceedings of the European Society of Pharmaco-vigilance, Berlin. Pharmacoepidemiology and Drug Safety 7 (Suppl 1): S4-10.
Wilton LV, Heeley E, Pickering RM, Shakir SA (2001) Comparative study of mortality rates and cardiac arrhythmias in post marketing surveillance studies of sertindole and two other atypical antipsychotic drugs. J Psychopharmacol, in press.
Wilton LV, MacKay FJ, Pearce GL, Mann RD (1997) The outcomes of pregnancy in women prescribed newly marketed drugs in 34 studies conducted by Prescription-Event Monitoring (PEM). Pharmacoepidemiology and Drug Safety 6(2): Abstract 072.
Wilton LV, Pearce GL, Edet E, et al. (1996) The safety of finasteride used in benign prostatic hypertrophy a non-interventional observational cohort study in 14 772 patients. Brit J Urol 78: 379-84.
Wilton LV, Stephens MDB, Mann RD (1999) Visual field defects association with Vigabatrin. Br Med J 319: 1165-6.
Witts, LJ (1965) Adverse reactions to drugs. Br Med J ii: 1081.
Was this article helpful?
Diabetes is a disease that affects the way your body uses food. Normally, your body converts sugars, starches and other foods into a form of sugar called glucose. Your body uses glucose for fuel. The cells receive the glucose through the bloodstream. They then use insulin a hormone made by the pancreas to absorb the glucose, convert it into energy, and either use it or store it for later use. Learn more...